Literature DB >> 26663229

Balloon test occlusion, device selection, and extracorporeal membrane oxygenation in the transcatheter closure of coronary artery fistula.

Mustafa Gülgün1, Muzaffer Kürşat Fidancı, Alparslan Fatih Genç.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26663229      PMCID: PMC5368460          DOI: 10.5152/AnatolJCardiol.2015.6735

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, We read with a great interest the paper by Zoghi et al. (1) entitled “Coil embolization of iatrogenic coronary-pulmonary arterial fistula after heart transplantation” published in the July issue of the Anatol J Cardiol 2015; 15: 587-8. They presented a successful transcatheter coil embolization of iatrogenic coronary-pulmonary fistula after heart transplantation in a 20-year-old male. We congratulate the authors for the successful intervention and clinical management of the case. However, we have a few technical comments. Our major concern is that immediately after release of the coil in the coronary artery, some residual flow is expected, which might potentially mask the evaluation of blood flow in the small right coronary artery efferents regard with ischemia. Therefore, we think that the transient balloon test occlusion of the fistula before releasing the device should be performed in such cases (2). The Amplatzer vascular plug (St. Jude Medical, Austin, TX) device as user-friendly and is attached to a flexible delivery cable that allows us to deliver the device through a smaller delivery catheter. In addition, a single plug is usually enough for the closure of the fistula, and this makes the vascular plug advantageous compared with multiple coil usage, which may result in increased fluoroscopy time, more contrast volume, and higher embolization risk because of high flow in arterial vessels (3, 4). Recently, the use of extracorporeal membrane oxygenation (ECMO) in elective high-risk complex percutaneous coronary intervention has been reported as an alternative method for hemodynamic support (5). In our opinion, it would be more helpful to be prepared for ECMO in hearttransplanted patients with a low systolic ejection fraction and requiring pacemaker support, as in the patient presented by Zoghi et al. (1).
  5 in total

1.  Evaluation of the AMPLATZER vascular plug for embolization of peripheral vascular malformations associated with congenital heart disease.

Authors:  S L Hill; Z M Hijazi; W E Hellenbrand; J P Cheatham
Journal:  Catheter Cardiovasc Interv       Date:  2006-01       Impact factor: 2.692

2.  Management of coronary artery fistulae. Patient selection and results of transcatheter closure.

Authors:  Laurie R Armsby; John F Keane; Megan C Sherwood; Joseph M Forbess; Stanton B Perry; James E Lock
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

3.  Outcome of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: A single-center experience.

Authors:  Salvatore Davide Tomasello; Marouane Boukhris; Vladimir Ganyukov; Alfredo R Galassi; Dmitri Shukevich; Boris Haes; Nikita Kochergin; Roman Tarasov; Vadim Popov; Leonid Barbarash
Journal:  Heart Lung       Date:  2015-04-23       Impact factor: 2.210

4.  Transcatheter closure of abnormal vessels and arteriovenous fistulas with the Amplatzer vascular plug 4 in patients with congenital heart disease.

Authors:  Gesa Wiegand; Ludger Sieverding; Wolfgang Bocksch; Michael Hofbeck
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

5.  Coil embolization of iatrogenic coronary-pulmonary arterial fistula after heart transplantation.

Authors:  Mehdi Zoghi; Celal Çınar; Mustafa Kurşun; Sanem Nalbantgil
Journal:  Anatol J Cardiol       Date:  2015-07       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.